Albany, NY (PRWEB) March 19, 2013
TechNavio's analysts forecast the Global Bio-implants market to grow at a CAGR of 7.38 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing prevalence of chronic diseases. The Global Bio-implants market has also been witnessing increasing market consolidation. However, the expensive nature of the bio-implant procedure could pose a challenge to the growth of this market.
To Read The Complete Report with TOC Visit: http://www.marketresearchreports.biz/analysis/164767
TechNavio's report, Global Bio-implants Market 2012-2016, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it covers the Global Bio-implants market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
The key vendors dominating this space are Medtronic Inc., Stryker Corp., Boston Scientific Corp., and Synthes Inc.
Related Report: http://www.marketresearchreports.biz/analysis/164766
The other vendors mentioned in the report are Smith and Nephew plc, Tornier Inc., Abbott Laboratories, aap Implantate AG, Biotronik SE and Co. KG, Edwards Lifesciences Corp., Sorin SpA, Zimmer Holdings Inc., Nobel Biocare Holding AG, Bausch and Lomb Inc., C.R. Bard Inc., LDR Holdings Corp., Amedica, Exactech, Pioneer Surgical, Ceraver Osteal America Inc., Corin Group plc, DJO Global Inc., Exactech Inc., Endotech Inc., Waldemar Link GmbH and Co. KG, Memometal Technologies S.A.S., Osteomed L.P., Wright Medical Group Inc., and Waldemar Link GmbH and Co. KG.
Copyright©2012 Vocus, Inc.
All rights reserved